Health Care Systems Research Collaboratory - Coordinating Center

卫生保健系统研究合作实验室 - 协调中心

• 批准号: 8463692
• 负责人: ROBERT M CALIFF
• 金额: $ 215.56万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-30 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8463692
• 关键词: Adopted; Back; Cessation of life; Clinical Research; Clinical Trials; Collaborations; Commit; Communication; Conduct Clinical Trials; Data; Data Sources; Development; Documentation; Education; Electronic Health Record; Funding; Generations; Goals; Guidelines; Health; Health Planning; Health Sciences; Health system; Healthcare; Healthcare Systems; Institute of Medicine (U.S.); Institutes; Integrated Delivery Systems; Learning; Link; Literature; Medical; Medical Technology; Methods; Multicenter Studies; Observational Study; Patient Outcomes Assessments; Patients; Policies; Private Practice; Procedures; Publications; Randomized Clinical Trials; Registries; Research; Research Infrastructure; Research Institute; Research Personnel; Site; Speed; System; Testing; United States National Institutes of Health; Universities; Work; base; care delivery; clinical care; collaboratory; cost; cost effectiveness; design; disability; expectation; experience; feeding; health care delivery; improved; medical schools; randomized trial; research study; systems research

We propose to create a Collaboratory Coordinating Center (Collaboratory CC) to work with the NIH to produce, document, and disseminate standards, and to create durable infrastructure that facilitates multicenter studies and reuse of data. The Collaboratory CC will be based at Duke University, with participation by the Harvard Pilgrim Health Care Institute at Harvard Medical School, the Group Health Research Institute, Johns Hopkins University and the Center for Medical Technology Policy. Our investigators have established multi-center research collaborations using electronic health records (EHRs), convened stakeholders to transform clinical trials, developed new regulatory approaches, and pioneered the use of patient-reported outcomes (PROs) in clinical research. This team has extensive experience in conducting both conventional and cluster randomized clinical trials, quasi-experimental studies, and observational studies across the spectrum of health systems, including integrated delivery systems and health plans, academic health and science systems, and private practices. The critical importance of this effort is reinforced by recent literature demonstrating that the vast majority of medical decisions are not supported by high quality evidence and that the clinical trials system is focused on small trials without sufficient power to fully inform practice or policy. In the face of this evidence gap the Institute of Medicine has called for a transformation of clinical trials rather than incremental improvements. This transformation should deal with the current fundamental separation of the conduct of clinical trials from the delivery of clinical care by involving practitioners and their health systems in th design and interpretation of trials, providing the broad education needed to enhance the value of practitioner participation and using the data collected as part of healthcare delivery as the core data source for the full spectrum of clinical research, from registries to observational studies an randomized trials. We believe that we are at a "tipping point", that if propelled by a powerful Collaboratory effort, will enjoin multiple public and private entities towards the common goal of a Learning Health System. At the end of the five-year funding period, new policies, procedures, governance capabilities, and a substantial infrastructure will enable larger, simpler, less expensive and more relevant clinical trials that will be an integral component of the healthcare system.

我们建议创建一个合作实验室协调中心(ColLabel CC)，与美国国立卫生研究院合作，制定、记录和传播标准，并创建持久的基础设施，促进多中心研究和数据的重复使用。合作实验室CC将设在杜克大学，哈佛医学院哈佛朝圣者健康研究所、团体健康研究所、约翰霍普金斯大学和医疗技术政策中心将参与其中。我们的研究人员使用电子健康记录(EHR)建立了多中心研究合作，召集利益相关者改变临床试验，开发新的监管方法，并率先在临床研究中使用患者报告结果(PRO)。该团队在进行常规和集群随机临床试验、准实验研究和跨卫生系统范围的观察性研究方面拥有丰富的经验，包括综合提供系统和卫生计划、学术卫生和科学系统以及私人实践。 最近的文献表明，绝大多数医学决定没有高质量的证据支持，临床试验系统侧重于小型试验，而没有足够的权力充分告知实践或政策，这一努力的关键重要性得到了加强。面对这一证据差距，医学研究所呼吁对临床试验进行改革，而不是逐步改进。这一转变应处理当前临床试验的进行与临床护理的提供的根本分离，方法是让从业者及其卫生系统参与试验的设计和解释，提供所需的广泛教育，以提高从业者参与的价值，并将作为医疗保健提供一部分收集的数据用作从注册到观察性研究和随机试验的所有临床研究的核心数据来源。我们相信，我们正处于一个“临界点”，如果在强大的合作实验室努力的推动下，将促使多个公共和私人实体朝着共同的目标努力 学习卫生系统。 在五年资助期结束时，新的政策、程序、治理能力和大量的基础设施将使更大、更简单、更便宜和更相关的临床试验成为医疗保健系统的一个组成部分。